131 related articles for article (PubMed ID: 24556168)
1. Association between ERCC2 Lys751Gln polymorphism and lung cancer risk: a meta-analysis involving 23,370 subjects.
Tan X; Xian L; Chen X; Shi L; Wang Y; Guo J; Liang G; Zhao Z; Chen M
Twin Res Hum Genet; 2014 Apr; 17(2):99-107. PubMed ID: 24556168
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism of ERCC2 Asp312Asn with lung cancer risk: evidence from 20,101 subjects.
Tan X; Wang Y; Shi L; Xian L; Guo J; Liang G; Chen M
Genet Test Mol Biomarkers; 2014 Jan; 18(1):50-6. PubMed ID: 24083550
[TBL] [Abstract][Full Text] [Related]
3. ERCC2/XPD Lys751Gln and Asp312Asn gene polymorphism and lung cancer risk: a meta-analysis involving 22 case-control studies.
Zhan P; Wang Q; Wei SZ; Wang J; Qian Q; Yu LK; Song Y
J Thorac Oncol; 2010 Sep; 5(9):1337-45. PubMed ID: 20651612
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism of the DNA repair gene ERCC2 Lys751Gln and risk of lung cancer in a northeastern Chinese population.
Yin J; Vogel U; Ma Y; Guo L; Wang H; Qi R
Cancer Genet Cytogenet; 2006 Aug; 169(1):27-32. PubMed ID: 16875933
[TBL] [Abstract][Full Text] [Related]
5. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH
World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049
[TBL] [Abstract][Full Text] [Related]
6. DNA repair pathway genes and lung cancer susceptibility: a meta-analysis.
Li W; Li K; Zhao L; Zou H
Gene; 2014 Apr; 538(2):361-5. PubMed ID: 24368330
[TBL] [Abstract][Full Text] [Related]
7. Association between ERCC2 Lys751Gln polymorphism and the risk of pancreatic cancer, especially among Asians: evidence from a meta-analysis.
Wu Y; Lu ZP; Zhang JJ; Liu DF; Shi GD; Zhang C; Qin ZQ; Zhang JZ; He Y; Wu PF; Miao Y; Jiang KR
Oncotarget; 2017 Jul; 8(30):50124-50132. PubMed ID: 28223548
[TBL] [Abstract][Full Text] [Related]
8. XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.
Qiu LX; Yao L; Zhang J; Zhu XD; Zhao XM; Xue K; Mao C; Chen B; Zhan P; Yuan H; Hu XC
Breast Cancer Res Treat; 2010 Nov; 124(1):229-35. PubMed ID: 20204500
[TBL] [Abstract][Full Text] [Related]
9. Increased cancer risk associated with the -607C/A polymorphism in interleukin-18 gene promoter: an updated meta-analysis including 12,502 subjects.
Li X; Ren D; Li Y; Xu J; Liu C; Zhao Y
J BUON; 2015; 20(3):902-17. PubMed ID: 26214646
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of excision repair cross-complementing group 2 gene Lys751Gln and Asp312Asn polymorphisms in melanoma risk.
Zhou X; Zeng Y; Jiang H; Xia L; Liu C
Melanoma Res; 2018 Aug; 28(4):311-318. PubMed ID: 29768284
[TBL] [Abstract][Full Text] [Related]
11. Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis.
Yuan H; Niu YM; Wang RX; Li HZ; Chen N
Genet Mol Res; 2011 Nov; 10(4):3356-64. PubMed ID: 22179996
[TBL] [Abstract][Full Text] [Related]
12. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
[TBL] [Abstract][Full Text] [Related]
13. DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis.
Hu Z; Wei Q; Wang X; Shen H
Lung Cancer; 2004 Oct; 46(1):1-10. PubMed ID: 15364127
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.
Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):359-65. PubMed ID: 12692111
[TBL] [Abstract][Full Text] [Related]
15. Association of ERCC1 C8092A and ERCC2 Lys751Gln polymorphisms with the risk of glioma: a meta-analysis.
Xin Y; Hao S; Lu J; Wang Q; Zhang L
PLoS One; 2014; 9(4):e95966. PubMed ID: 24763305
[TBL] [Abstract][Full Text] [Related]
16. The effect of XPD/ERCC2 Lys751Gln polymorphism on acute leukemia risk: a systematic review and meta-analysis.
Liu D; Wu D; Li H; Dong M
Gene; 2014 Apr; 538(2):209-16. PubMed ID: 24486506
[TBL] [Abstract][Full Text] [Related]
17. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
Xu TP; Shen H; Liu LX; Shu YQ
Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
[TBL] [Abstract][Full Text] [Related]
18. ERCC2 Lys751Gln polymorphism is associated with lung cancer among Caucasians.
Zhang J; Gu SY; Zhang P; Jia Z; Chang JH
Eur J Cancer; 2010 Sep; 46(13):2479-84. PubMed ID: 20627704
[TBL] [Abstract][Full Text] [Related]
19. Association between C-reactive protein gene +1059 G/C polymorphism and the risk of coronary heart disease: a meta-analysis.
Li CS; Guo BR; Guo Z; Yang J; Zheng HF; Wang AL
Chin Med J (Engl); 2013; 126(24):4780-5. PubMed ID: 24342328
[TBL] [Abstract][Full Text] [Related]
20. Association between BRCA1 rs799917 polymorphism and breast cancer risk: A meta-analysis of 19,878 subjects.
Qin TT; Chen T; Zhang Q; Du HN; Shu YQ; Luo K; Zhu LJ
Biomed Pharmacother; 2014 Sep; 68(7):905-10. PubMed ID: 25194442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]